Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 600

1.

Towards diagnostic markers for the psychoses.

Lawrie SM, O'Donovan MC, Saks E, Burns T, Lieberman JA.

Lancet Psychiatry. 2016 Apr;3(4):375-85. doi: 10.1016/S2215-0366(16)00021-3. Review.

PMID:
27063388
2.

Improving classification of psychoses.

Lawrie SM, O'Donovan MC, Saks E, Burns T, Lieberman JA.

Lancet Psychiatry. 2016 Apr;3(4):367-74. doi: 10.1016/S2215-0366(15)00577-5. Review.

PMID:
27063387
3.

Mechanisms of Working Memory Impairment in Schizophrenia.

Van Snellenberg JX, Girgis RR, Horga G, van de Giessen E, Slifstein M, Ojeil N, Weinstein JJ, Moore H, Lieberman JA, Shohamy D, Smith EE, Abi-Dargham A.

Biol Psychiatry. 2016 Feb 23. pii: S0006-3223(16)00129-3. doi: 10.1016/j.biopsych.2016.02.017. [Epub ahead of print]

PMID:
27056754
4.

A multicenter, rater-blinded, randomized controlled study of auditory processing-focused cognitive remediation combined with open-label lurasidone in patients with schizophrenia and schizoaffective disorder.

Kantrowitz JT, Sharif Z, Medalia A, Keefe RS, Harvey P, Bruder G, Barch DM, Choo T, Lee S, Lieberman JA.

J Clin Psychiatry. 2016 Mar 15. [Epub ahead of print]

PMID:
27035157
5.

A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia.

Girgis RR, Van Snellenberg JX, Glass A, Kegeles LS, Thompson JL, Wall M, Cho RY, Carter CS, Slifstein M, Abi-Dargham A, Lieberman JA.

J Psychopharmacol. 2016 May;30(5):428-35. doi: 10.1177/0269881116636120. Epub 2016 Mar 10.

PMID:
26966119
6.

Genetic association analysis of N-methyl-d-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.

Taylor DL, Tiwari AK, Lieberman JA, Potkin SG, Meltzer HY, Knight J, Remington G, Müller DJ, Kennedy JL.

Hum Psychopharmacol. 2016 Mar;31(2):121-34. doi: 10.1002/hup.2519. Epub 2016 Feb 15.

PMID:
26876050
7.

Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.

Huang E, Zai CC, Lisoway A, Maciukiewicz M, Felsky D, Tiwari AK, Bishop JR, Ikeda M, Molero P, Ortuno F, Porcelli S, Samochowiec J, Mierzejewski P, Gao S, Crespo-Facorro B, Pelayo-Terán JM, Kaur H, Kukreti R, Meltzer HY, Lieberman JA, Potkin SG, Müller DJ, Kennedy JL.

Int J Neuropsychopharmacol. 2016 Jan 8. pii: pyv132. doi: 10.1093/ijnp/pyv132. [Epub ahead of print]

8.

Brain Regions Associated With Internalizing and Externalizing Psychiatric Symptoms in Patients With Penetrating Traumatic Brain Injury.

Huey ED, Lee S, Lieberman JA, Devanand DP, Brickman AM, Raymont V, Krueger F, Grafman J.

J Neuropsychiatry Clin Neurosci. 2016 Spring;28(2):104-11. doi: 10.1176/appi.neuropsych.15060150. Epub 2015 Dec 30.

PMID:
26715034
9.

The year in review: the best of 2015 in the Annals.

Marshall GD Jr, Grayson MH, Ellis AK, Hsieh FH, Oppenheimer J, Desai M, Lieberman JA, Greenhawt M, Montanaro A, Bielory L.

Ann Allergy Asthma Immunol. 2016 Jan;116(1):2-8. doi: 10.1016/j.anai.2015.10.025. No abstract available.

PMID:
26707769
10.

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.

Huang E, Maciukiewicz M, Zai CC, Tiwari AK, Li J, Potkin SG, Lieberman JA, Meltzer HY, Müller DJ, Kennedy JL.

Pharmacogenomics. 2016;17(2):103-9. doi: 10.2217/pgs.15.155. Epub 2015 Dec 15.

PMID:
26666695
11.

How much is too much . . . And in what setting?

Lieberman JA.

J Allergy Clin Immunol. 2016 Mar;137(3):967. doi: 10.1016/j.jaci.2015.09.046. Epub 2015 Nov 24. No abstract available.

PMID:
26620590
12.

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain.

Tiwari AK, Brandl EJ, Zai CC, Goncalves VF, Chowdhury NI, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

World J Biol Psychiatry. 2016 Apr;17(3):221-9. doi: 10.3109/15622975.2015.1076173. Epub 2015 Oct 8.

PMID:
26447462
13.

ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial.

Lieberman JA, Davis RE, Correll CU, Goff DC, Kane JM, Tamminga CA, Mates S, Vanover KE.

Biol Psychiatry. 2015 Aug 31. pii: S0006-3223(15)00694-0. doi: 10.1016/j.biopsych.2015.08.026. [Epub ahead of print]

14.

Response to Kornfeld.

Lieberman JA.

Am J Psychiatry. 2015 Sep 1;172(9):911. doi: 10.1176/appi.ajp.2015.15070863r. No abstract available.

PMID:
26324309
15.

Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.

Brandl EJ, Tiwari AK, Zai CC, Nurmi EL, Chowdhury NI, Arenovich T, Sanches M, Goncalves VF, Shen JJ, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

Pharmacogenomics J. 2015 Sep 1. doi: 10.1038/tpj.2015.59. [Epub ahead of print]

PMID:
26323598
16.

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis.

Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, Zhao Q, Kendler KS, Sullivan PF, Price AL, O'Donovan M, Okada Y, Mowry BJ, Raychaudhuri S, Wray NR; Schizophrenia Working Group of the Psychiatric Genomics Consortium and Rheumatoid Arthritis Consortium International; Schizophrenia Working Group of the Psychiatric Genomics Consortium Authors, Byerley W, Cahn W, Cantor RM, Cichon S, Cormican P, Curtis D, Djurovic S, Escott-Price V, Gejman PV, Georgieva L, Giegling I, Hansen TF, Ingason A, Kim Y, Konte B, Lee PH, McIntosh A, McQuillin A, Morris DW, Nöthen MM, O'Dushlaine C, Olincy A, Olsen L, Pato CN, Pato MT, Pickard BS, Posthuma D, Rasmussen HB, Rietschel M, Rujescu D, Schulze TG, Silverman JM, Thirumalai S, Werge T; Schizophrenia Working Group of the Psychiatric Genomics Consortium Collaborators, Agartz I, Amin F, Azevedo MH, Bass N, Black DW, Blackwood DH, Bruggeman R, Buccola NG, Choudhury K, Cloninger RC, Corvin A, Craddock N, Daly MJ, Datta S, Donohoe GJ, Duan J, Dudbridge F, Fanous A, Freedman R, Freimer NB, Friedl M, Gill M, Gurling H, De Haan L, Hamshere ML, Hartmann AM, Holmans PA, Kahn RS, Keller MC, Kenny E, Kirov GK, Krabbendam L, Krasucki R, Lawrence J, Lencz T, Levinson DF, Lieberman JA, Lin DY, Linszen DH, Magnusson PK, Maier W, Malhotra AK, Mattheisen M, Mattingsdal M, McCarroll SA, Medeiros H, Melle I, Milanova V, Myin-Germeys I, Neale BM, Ophoff RA, Owen MJ, Pimm J, Purcell SM, Puri V, Quested DJ, Rossin L, Ruderfer D, Sanders AR, Shi J, Sklar P, St Clair D, Stroup TS, Van Os J, Visscher PM, Wiersma D, Zammit S; Rheumatoid Arthritis Consortium International Authors, Bridges SL Jr, Choi HK, Coenen MJ, de Vries N, Dieud P, Greenberg JD, Huizinga TW, Padyukov L, Siminovitch KA, Tak PP, Worthington J; Rheumatoid Arthritis Consortium International Collaborators, De Jager PL, Denny JC, Gregersen PK, Klareskog L, Mariette X, Plenge RM, van Laar M, van Riel P.

Int J Epidemiol. 2015 Oct;44(5):1706-21.

PMID:
26286434
17.

Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNO.

Girgis RR, Xu X, Gil RB, Hackett E, Ojeil N, Lieberman JA, Slifstein M, Abi-Dargham A.

Schizophr Res. 2015 Oct;168(1-2):373-6. doi: 10.1016/j.schres.2015.06.027. Epub 2015 Jul 17.

PMID:
26190300
18.

Pharmacotherapy for eosinophilic esophagitis.

Lieberman JA.

Ann Allergy Asthma Immunol. 2015 May;114(5):357-63. doi: 10.1016/j.anai.2015.03.014. Review. No abstract available.

PMID:
25952635
19.

Type IV pilus secretins have extracellular C termini.

Lieberman JA, Petro CD, Thomas S, Yang A, Donnenberg MS.

MBio. 2015 Mar 24;6(2). pii: e00322-15. doi: 10.1128/mBio.00322-15.

20.

Implementing Coordinated Specialty Care for Early Psychosis: The RAISE Connection Program.

Dixon LB, Goldman HH, Bennett ME, Wang Y, McNamara KA, Mendon SJ, Goldstein AB, Choi CW, Lee RJ, Lieberman JA, Essock SM.

Psychiatr Serv. 2015 Jul;66(7):691-8. doi: 10.1176/appi.ps.201400281. Epub 2015 Mar 16.

PMID:
25772764
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk